Literature DB >> 33394043

HDACs and MYC in medulloblastoma: how do HDAC inhibitors control MYC-amplified tumors?

Tomoko Shofuda1, Yonehiro Kanemura1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33394043      PMCID： PMC7906052          DOI： 10.1093/neuonc/noaa292

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  7 in total

1.  HDAC and MAPK/ERK Inhibitors Cooperate To Reduce Viability and Stemness in Medulloblastoma.

Authors:  Mariane da Cunha Jaeger; Eduarda Chiesa Ghisleni; Paula Schoproni Cardoso; Marialva Siniglaglia; Tiago Falcon; André T Brunetto; Algemir L Brunetto; Caroline Brunetto de Farias; Michael D Taylor; Carolina Nör; Vijay Ramaswamy; Rafael Roesler
Journal:  J Mol Neurosci       Date:  2020-02-13       Impact factor: 3.444

2.  HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC-Driven Medulloblastoma.

Authors:  Yanxin Pei; Kun-Wei Liu; Jun Wang; Alexandra Garancher; Ran Tao; Lourdes A Esparza; Donna L Maier; Yoko T Udaka; Najiba Murad; Sorana Morrissy; Huriye Seker-Cin; Sebastian Brabetz; Lin Qi; Mari Kogiso; Simone Schubert; James M Olson; Yoon-Jae Cho; Xiao-Nan Li; John R Crawford; Michael L Levy; Marcel Kool; Stefan M Pfister; Michael D Taylor; Robert J Wechsler-Reya
Journal:  Cancer Cell       Date:  2016-03-14       Impact factor: 31.743

Review 3.  The many roles of histone deacetylases in development and physiology: implications for disease and therapy.

Authors:  Michael Haberland; Rusty L Montgomery; Eric N Olson
Journal:  Nat Rev Genet       Date:  2009-01       Impact factor: 53.242

Review 4.  Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.

Authors:  Vijay Ramaswamy; Marc Remke; Eric Bouffet; Simon Bailey; Steven C Clifford; Francois Doz; Marcel Kool; Christelle Dufour; Gilles Vassal; Till Milde; Olaf Witt; Katja von Hoff; Torsten Pietsch; Paul A Northcott; Amar Gajjar; Giles W Robinson; Laetitia Padovani; Nicolas André; Maura Massimino; Barry Pizer; Roger Packer; Stefan Rutkowski; Stefan M Pfister; Michael D Taylor; Scott L Pomeroy
Journal:  Acta Neuropathol       Date:  2016-04-04       Impact factor: 17.088

5.  Molecular subgroups of medulloblastoma: the current consensus.

Authors:  Michael D Taylor; Paul A Northcott; Andrey Korshunov; Marc Remke; Yoon-Jae Cho; Steven C Clifford; Charles G Eberhart; D Williams Parsons; Stefan Rutkowski; Amar Gajjar; David W Ellison; Peter Lichter; Richard J Gilbertson; Scott L Pomeroy; Marcel Kool; Stefan M Pfister
Journal:  Acta Neuropathol       Date:  2011-12-02       Impact factor: 17.088

6.  Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma.

Authors:  Jonas Ecker; Ina Oehme; Ralph Mazitschek; Andrey Korshunov; Marcel Kool; Thomas Hielscher; Judit Kiss; Florian Selt; Carina Konrad; Marco Lodrini; Hedwig E Deubzer; Andreas von Deimling; Andreas E Kulozik; Stefan M Pfister; Olaf Witt; Till Milde
Journal:  Acta Neuropathol Commun       Date:  2015-04-03       Impact factor: 7.801
  7 in total
  2 in total

Review 1.  Bombesin Receptor Family Activation and CNS/Neural Tumors: Review of Evidence Supporting Possible Role for Novel Targeted Therapy.

Authors:  Terry W Moody; Lingaku Lee; Irene Ramos-Alvarez; Tatiana Iordanskaia; Samuel A Mantey; Robert T Jensen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-01       Impact factor: 5.555

2.  Clinically aggressive pediatric spinal ependymoma with novel MYC amplification demonstrates molecular and histopathologic similarity to newly described MYCN-amplified spinal ependymomas.

Authors:  Margaret Shatara; Kathleen M Schieffer; Darren Klawinski; Diana L Thomas; Christopher R Pierson; Eric A Sribnick; Jeremy Jones; Diana P Rodriguez; Carol Deeg; Elizabeth Hamelberg; Stephanie LaHaye; Katherine E Miller; James Fitch; Benjamin Kelly; Kristen Leraas; Ruthann Pfau; Peter White; Vincent Magrini; Richard K Wilson; Elaine R Mardis; Mohamed S Abdelbaki; Jonathan L Finlay; Daniel R Boué; Catherine E Cottrell; David R Ghasemi; Kristian W Pajtler; Diana S Osorio
Journal:  Acta Neuropathol Commun       Date:  2021-12-11       Impact factor: 7.801
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.